openPR Logo
Press release

Retinal Disorders – Therapy Market Snapshot

11-08-2017 09:05 AM CET | Health & Medicine

Press release from: ReportsWorldwide

Boston, MA

ReportsWorldwide has announced the addition of a new report title Retinal Disorders – Therapy Market Snapshot to its growing collection of premium market research reports.

A range of disorders, some of which share similar underlying pathologies, can affect the retina and lead to progressively worsening vision and eventual blindness. The retina is the layer of light-sensitive tissue at the back of the eye that converts light into impulses to the brain via the optic nerve. A common feature of certain retinal disorders is abnormal growth of blood vessels in the macula, which can be effectively treated by drugs targeting vascular endothelial growth factor. These discrete indications are wet age-related macular degeneration, diabetic retinopathy with and without diabetic macular edema, and macular edema from retinal vein occlusion.

The report of 142 pages, 40 tables and 35 figures covers the below topics in detail:

• Treatment
• Marketed Drugs –Profiles of Avastin, Eylea, Lucentis and Ozurdex
• Drug Pipeline – Late stage product profiles of Zuprata, abicipar pegol, brolucizumab and squalamine

For a Detailed description and table of contents of this Datamonitor Healthcare report please click here: https://www.reportsworldwide.com/report/retinal-disorders

Below is a Snapshot of Retina Disorders therapy market :

• New therapies will sustain market growth beyond expiries for first-generation anti-VEGF injections.
• Anti-VEGFs lead treatment dynamics, although choice of specific therapy is widely variable between countries.
• Common retinal disorders will contribute to over four million cases in 2016; this is expected to rise in the future.
• Eylea has become the clinical gold standard and market-leading anti-VEGF therapy.
• Brolucizumab’s Phase III data position it as a direct competitor to the $5bn VEGF inhibitor Eylea.

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=42264

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-1947
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Disorders – Therapy Market Snapshot here

News-ID: 806682 • Views: 239

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for VEGF

Vascular Endothelial Growth Factor (VEGF) Antibodies Market By 2026 Genentech, N …
Vascular Endothelial Growth Factor (VEGF) is a signal protein that helps in the formation of new blood vessels through a process known as angiogenesis. Vascular endothelial growth factor is a part of several pathological processes and researches are often carried out for the development of novel therapies using these factors for diseases such as cancer. Normal functions of vascular endothelial growth factor includes embryonic development, formation of new blood vessels,
Vascular Endothelial Growth Factor (VEGF) Antibodies Market Trends, Outlook, and …
Vascular Endothelial Growth Factor (VEGF) is a signal protein that helps in the formation of new blood vessels through a process known as angiogenesis. Vascular endothelial growth factor is a part of several pathological processes and researches are often carried out for the development of novel therapies using these factors for diseases such as cancer. Normal functions of vascular endothelial growth factor includes embryonic development, formation of new blood vessels,
Vascular Endothelial Growth Factor (VEGF) Antibodies Market Opportunity Analysis …
Vascular Endothelial Growth Factor (VEGF) is a signal protein that helps in the formation of new blood vessels through a process known as angiogenesis. Vascular endothelial growth factor is a part of several pathological processes and researches are often carried out for the development of novel therapies using these factors for diseases such as cancer. Normal functions of vascular endothelial growth factor includes embryonic development, formation of new blood vessels,
Market Insights: Anti-VEGF Drugs to Remain Preferred for Treatment of Proliferat …
Researchmoz added Most up-to-date research on "Proliferative Diabetic Retinopathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026" to its huge collection of research reports. Proliferative diabetic retinopathy prevails as leading cause of blindness across industrialized countries worldwide. Although remarkable advancements have been made in the diagnosis and treatment of the disease, several imperative management questions as well as treatment deficiencies continue to persist unanswered. The
Vascular Endothelial Growth Factor (VEGF) Antibodies Market Report Explored in L …
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market: Overview Vascular endothelial growth factor is an integral part of several pathophysiological processes. This is the primary reason why it is extensively used for designing therapies to treat patients with macular degeneration and cancers. The global vascular endothelial growth factor (VEGF) antibodies is gaining momentum as it is known to be far more effective than conventional pharmaceuticals. Currently, VEGF antibodies used for treating
Global Ophthalmic Therapeutics-Drug Market By Type | Antiallergy, Anti-VEGF agen …
Researchmoz added Most up-to-date research on "Global Ophthalmic Therapeutics-Drug Market By Type | Antiallergy, Anti-VEGF agents, Anti-inflammatory and Antiglaucoma" to its huge collection of research reports. This report studies the global Ophthalmic Therapeutics/Drug market, analyzes and researches the Ophthalmic Therapeutics/Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Novartis AG Allergan Santen Pharmaceutical Co., Ltd. Pfizer Inc. Merck &